Efficacy of liraglutide in non-diabetic obese adults: a systematic review and meta-analysis of randomized controlled trials

JJ Barboza, MR Huaman, B Melgar… - Journal of Clinical …, 2022 - mdpi.com
Objective: We systematically assessed the efficacy of liraglutide in non-diabetic obese
adults. Methods: Six databases were searched up to July 2021 for randomized controlled …

Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis

G Zhou, S Verweij, MJ Bijlsma… - BMJ open …, 2023 - bmjopenrespres.bmj.com
Objective Current evidence on the effectiveness of SARS-CoV-2 prophylaxis is inconclusive.
We aimed to systematically evaluate published studies on repurposed drugs for the …

Antirheumatic drug intake influence on occurrence of COVID-19 infection in ambulatory patients with immune-mediated inflammatory diseases: a cohort study

D Guillaume, B Magalie, E Sina, SM Imene… - Rheumatology and …, 2021 - Springer
Introduction We aimed to study the prevalence of a history of COVID-19 infection among
patients suffering from systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) …

Concizumab en pacientes con Hemofilia A/B: una revisión sistemática

A Valle-Chafloque, K Uchofén-Mondragón… - Revista del Cuerpo …, 2022 - cmhnaaa.org.pe
Objetivo: Evaluamos sistemáticamente la eficacia de Concizumab en pacientes con
Hemofilia A/B. Material y Métodos: Se buscaron en cinco bases de datos hasta mayo de …

[PDF][PDF] PUBLICACIÓN ANTICIPADA

L Castillo, CJ Zumarán-Núñez, DF Dávila-Vigil… - 2022 - cmhnaaa.org.pe
Objective: We systematically assessed the efficacy of Concizumab in patients with
Hemophilia A/B. Material and Methods: Five databases were searched up to May 2022 for …

Hydroxichloroquine for COVID-19 infection: Do we have a final word after one year?

A Di Castelnuovo, S Costanzo, A Gialluisi… - European Journal of …, 2021 - Elsevier
The results presently available from randomised clinical trials and their meta-analysis
indicate that Hydroxychloroquine is not associated in COVID-19 patients with either …

[PDF][PDF] Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study

DGBM Elahi, SSMI Vayr, FD Mathieu, MAGYE Emma… - 2021 - scienceopen.com
Introduction: We aimed to study the prevalence of a history of COVID-19 infection among
patients suffering from systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) …